MeVis Medical Solutions AG reported preliminary earnings results for the year ended December 31, 2011. For the year, the company reported group turnover of approximately EUR 13.7 million compared to EUR 14.3 million for the previous year. EBITDA was around EUR 4.1 million compared to EUR 3.5 million a year ago. Group LBIT of approximately was EUR 1.7 million compared to EUR 5.4 million a year ago. Group EBIT before one-time charges was improved by approximately EUR 0.2 million to approximately EUR 0.9 million. The one-time charges impacting the EBIT consist of a non-cash impairment charge on intangible assets in the amount of approximately EUR 2.3 million for capitalized development expenses of Visia Software Applications since 2008. The financial result was impacted by a partial write-off of the 41% stake in the Dutch company Medis in the amount of EUR 0.9 million. This non-cash write-off was due to an adjusted assessment of the future development. The company announced that CEO, Dr. Carl Evertsz will leave the company on February 29, 2012.